Institute of Medicine (U.S.), Committee on Emerging Microbial Threats to Health. Emerging Infections: Microbial Threats to Health in the United States (National Academy Press, Washington, DC, 1992).
Halstead, S.B. The XXth century dengue pandemic: Need for surveillance and research. World Health Stat. Q.45, 292–298 (1992). CASPubMed Google Scholar
World Health Organization. Dengue and dengue hemorrhagic fever. Report N117. (World Health Organization, Geneva, 1996).
Centers for Disease Control. Dengue Fever at the U.S.–Mexico Border, 1995–1996. Morbid. Mortal. Weekly Rep.45, N39 (1996).
Tyler, K.L. & Fields, B.N. Pathogenesis of viral infections. in Fields Virology, 3rd edn., Vol. 1. (eds. Fields, B.N., Knipe, D.M. & Howley, P.M.) 173–217 (Lippincott-Raven, Philadelphia, 1996). Google Scholar
Wimmer, E. in Cellular Receptors for Animal Viruses. (ed. Wimmer, E.) 1–13 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1994). Google Scholar
Porterfield, J.S. Antibody-dependent enhancement of viral infectivity. Adv. Virus. Res.31, 335–355 (1986). ArticleCASPubMed Google Scholar
He, R.-T. et al. Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2. J. Med. Virol.45, 451–461 (1995). ArticleCASPubMed Google Scholar
Rice, C.M. Flaviviridae: The viruses and their replication. in Fields Virology, 3rd edn., Vol. 1. (eds. Fields, B.N., Knipe, D.M. & Howley, P.M.) 931–959 (Lippincott-Raven, Philadelphia, 1996). Google Scholar
Chen, Y., Maguire, T. & Marks, R.M. Demonstration of binding of dengue virus envelope protein to target cells. J. Virol.70, 8765–8772 (1996). CASPubMedPubMed Central Google Scholar
Couchman, J.R. & Woods, A. Structure and biology of pericellular proteoglycans. in Cell Structure and Extracellular Glycoconjugates, Vol. 1. (eds. Roberts, D.D. & Mecham, R.P.) 33–82 (Academic Press, New York, 1993). Chapter Google Scholar
Thompson, L.D., Pantoliano, M.W. & Springer, B.A. Energetic characterization of the basic fibroblast growth factor–heparin interaction: Identification of the heparin binding domain. Biochemistry33, 3831–3840 (1994). ArticleCASPubMed Google Scholar
Fromm, J.R., Hileman, R.E., Caldwell, E.E., Weiler, J.M. & Linhardt, R.J. Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. Arch. Biochem. Biophys.323, 279–287 (1995). ArticleCASPubMed Google Scholar
Toida, T., Imanari, T., Hileman, R.E., Fromm, J.R. & Linhardt, R.J. Structural differences in heparan sulfates from different tissues and species. Biochem. J.322, 499–506 (1997). ArticleCASPubMedPubMed Central Google Scholar
Linhardt, R.J. & Toida, T. Heparin oligosaccharides-new analogs development and application. in Carbohydrates as Drugs (eds. Witczak, Z.B. & Nieforth, K.A.) 277–341 (Marcel Dekker, New York, 1997). Google Scholar
Pervin, A., Callo, C., Jandik, K.A., Han, X.J. & Linhardt, R.J. Preparation and structural characterization of large heparin-derived oligosaccharides. Glycobiology5, 83–95 (1995). ArticleCASPubMed Google Scholar
Toida, T., Hileman, R.E., Smith, A.E., Vlahova, P.I. & Linhardt, R.J. Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites. J. Biol. Chem.271, 32040–32047 (1996). ArticleCASPubMed Google Scholar
Linhardt, R.J. Analysis of glycoconjugates. in Current Protocols in Molecular Biology, Vol. 2. (ed. Varki, A.) 17.13.17–17.13.32 (Wiley Interscience, Boston, 1994). Google Scholar
Bame, K.J. & Esko, J.D. Undersulfated heparan sulfate in a Chinese hamster ovary cell mutant defective in heparan sulfate _N_-sulfotransferase. J. Biol. Chem.264, 8059–8065 (1989). CASPubMed Google Scholar
Esko, J.D. et al. Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I. J. Biol. Chem.262, 12189–12195 (1987). CASPubMed Google Scholar
Lidholt, K. et al. A single mutation affects both _N_-acetylglucosaminyltransferaseand glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc. Notl. Acad. Sci. USA89, 2267–2271 (1992). ArticleCAS Google Scholar
Esko, J.D., Stewart, T.E. & Taylor, W.H. Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. USA82, 3197–3201 (1985). ArticleCASPubMedPubMed Central Google Scholar
Baeuerle, P.A. & Huttner, W.B. Chlorate–a potent inhibitor of protein sulfation in intact cells. Biochem. Biophys. Res. Commun.141, 870–877 (1986). ArticleCASPubMed Google Scholar
Raake, W., Klauser, R.J., Elling, H. & Meinetsberger, E. Anticoagulant and an-tithrombotic properties of synthetic sulfated _bis_-lactobionic acid amides. Thromb. Res.56, 719–730 (1989). ArticleCASPubMed Google Scholar
Sternbergh, W.C., Sobel, M. & Makhoul, R.G. Heparinoids with low anticoagulant potency attenuate postischemic endothelial cell dysfunction. J. Vasc. Surg.21, 477–483 (1995). ArticlePubMed Google Scholar
Mohan, P., Hopfinger, A.J. & Baba, M. Naphthalenedisulfonic acid derivatives as potential anti-HIV agents: Chemistry, biology and molecular modeling of their inhibition of reverse transcriptase. Antiviral Chem. Chemother.2, 215–222 (1991). ArticleCAS Google Scholar
Cardin, A.D. & Weintraub, H.J. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis9, 21–32 (1989). ArticleCASPubMed Google Scholar
Faham, S., Hileman, R.E., Fromm, J.R., Linhardt, R.J. & Rees, D.C. Heparin structure and interactions with basic fibroblast growth factor. Science271, 1116–1120 (1996). ArticleCASPubMed Google Scholar
Chen, W.-B. & Maguire, T. Nucleotide sequence of the envelope glycoprotein gene of a dengue-2 virus isolated during an epidemic of benign dengue fever in Tonga in 1974. Nucleic Acids Res.18, 5889 (1990). ArticleCASPubMedPubMed Central Google Scholar
Rey, F.A., Heinz, F.X., Mandl, C., Kunz, C. & Harrison, S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature375, 291–298 (1995). ArticleCASPubMed Google Scholar
Peitsch, M.C. ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling. Biochem. Soc. Trans.24, 274–279 (1996). ArticleCASPubMed Google Scholar
Bork, P., Holm, L. & Sander, C. The immunoglobulin fold. Structural classification sequence patterns and common core. J. Mol. Biol.242, 309–320 (1994). CASPubMed Google Scholar
McClain, D.S. & Fuller, O. Cell-specific kinetics and efficiency of herpes simplex virus type 1 entry are determined by two distinct phases of attachment. Virology198, 690–702. (1994). ArticleCASPubMed Google Scholar
Montgomery, R.I., Warner, M.S., Lum, B.J. & Spear, P. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NCF receptor family. Cell87, 427–436 (1996). ArticleCASPubMed Google Scholar
Maccarana, M., Sakura, Y., Tawada, A., Yoshida, K. & Lindahl;, U. Domain structure of heparan sulfates from bovine organs. J. Biol. Chem.271, 17804–17810 (1996). ArticleCASPubMed Google Scholar
Jackson, T. et al. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol.70, 5282–5287 (1996). CASPubMedPubMed Central Google Scholar
Ortega-Barria, E. & Pereira, M.E. A novel T.cruzi heparin-binding protein promotes fibroblast adhesion and penetration of engineered bacteria and trypanosomes into mammalian cells. Cell67, 411–421 (1991). ArticleCASPubMed Google Scholar
Ruoslahti, E. & Pierschbacher, M.D. New perspectives in cell adhesion: RGD and integrins. Science238, 491–497 (1987). ArticleCASPubMed Google Scholar
Sanchez, I.J. & Ruiz, B.H. A single nucleotide change in the E protein of dengue virus 2 Mexican strain affects neurovirulence in mice. J. Gen. Virol.77, 2541–2545 (1996). ArticleCASPubMed Google Scholar
Lin, B., Parrish, C.R., Murray, J.M. & Wright, P.J. Localization of a neutralization epi-tope on the envelope protein of dengue virus type 2. Virology202, 885–890 (1994). ArticleCASPubMed Google Scholar
Jiang, W.R., Lowe, A., Higgs, S., Reid, H. & Gould, E.A. Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence. J. Gen. Virol.74, 931–935 (1993). ArticleCASPubMed Google Scholar
Jennings, A.D. et al. Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J. Infect. Dis.169, 512–518 (1994). ArticleCASPubMed Google Scholar
Holzmann, H., Heinz, F.X., Mandl, C.W., Guirakhoo, F. & Kunz, C. A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J. Virol.64, 5156–5159 (1990). CASPubMedPubMed Central Google Scholar
Cecilia, D. & Gould, E.A. Nucleotide changes responsible for loss of neuroinvasive-ness in Japanese encephalitis virus neutralization-resistant mice. Virology181, 70–77 (1991). ArticleCASPubMed Google Scholar
Reed, L.J. & Muench, H. A simple method of estimating fifty per cent end points. Am. J. Hygiene27, 493–497. (1938). Google Scholar
Ojala, W.H. et al. Complexes of lysine, histidine and arginine with sulfonated azo dyes: Model systems for understanding the biomolecular recognition of glycosaminoglycans by proteins. J. Am. Chem. Soc.118, 2131–2142 (1996). ArticleCAS Google Scholar